Business Context and Reporting Period
This filing is the Form 10-K of Ambac Financial Group, Inc. for the fiscal year ended December 31, 2021. The source text identifies Ambac, not Octave Specialty Group Inc. Ambac operates three principal platforms: legacy financial guarantee insurance in runoff since 2008, specialty property and casualty program insurance through Everspan, and managing general agency/underwriting operations through its 80%-owned Xchange businesses.
In 2021, Ambac continued to de-risk its financial guarantee portfolio while developing Everspan and expanding its specialty insurance platform. Everspan launched its first program in May 2021, received an “A-” AM Best financial strength rating, and issued approximately $13 million of gross written premium while retaining approximately 20% of the risk. Xchange underwrote approximately $118 million of carrier premiums and generated $26 million of gross commission revenue.
Financial Results and Key Metrics
| Metric | 2021 | 2020 | Change |
|---|---|---|---|
| Net premiums earned | $47 million | $54 million | Down 13% |
| Net investment income | $139 million | $122 million | Up $17 million |
| Net investment gains | $7 million | $22 million | Down $15 million |
| Net derivative gains/(losses) | $22 million | $(50) million | Improved $72 million |
| Gain on debt extinguishment | $33 million | $0 | New in 2021 |
| Losses and loss expenses | $(88) million benefit | $225 million expense | Favorable $313 million |
| Operating expenses | $126 million | $92 million | Up 37% |
| Interest expense | $187 million | $222 million | Down 16% |
| Net loss attributable to common stockholders | $(17) million | $(437) million | Improved $420 million |
| Diluted loss per share | $(0.61) | $(9.47) | Improved |
| Adjusted earnings | $43 million | $(378) million | Improved $421 million |
Total assets were $12.3 billion, down from $13.2 billion. Total liabilities were $11.2 billion, down from $12.1 billion. Total stockholders’ equity was $1.098 billion, compared with $1.140 billion at year-end 2020. Adjusted book value was $874 million, or $18.88 per share, compared with $919 million, or $20.05 per share.
Operating cash flow remained negative at $(131) million, compared with $(175) million in 2020. Investing activities provided $776 million, while financing activities used $657 million, primarily reflecting debt refinancing and repayments. Ending cash, cash equivalents and restricted cash were $23 million, compared with $35 million in 2020.
Consolidated investments totaled approximately $2.955 billion at fair value, including $1.745 billion of long-term fixed maturity investments, $519 million of short-term investments and $690 million of other investments. A hypothetical 100-basis-point increase in interest rates would have reduced the fair value of the fixed maturity portfolio by approximately $50 million.
Debt, Liquidity and Capital
- Non-VIE long-term debt was $2.230 billion at December 31, 2021, compared with $2.739 billion at year-end 2020.
- Ambac refinanced the $1.641 billion LSNI Ambac Note through the issuance of the $1.175 billion Sitka AAC Note, with net proceeds of $1.163 billion. The Sitka note bears interest at three-month USD LIBOR plus 4.50%, subject to a 0.75% floor, and matures in 2026.
- AAC’s surplus notes had a $785 million principal balance and $576 million of accrued and unpaid interest to third parties. OCI declined approval of scheduled principal and interest payments in 2021; future payments remain uncertain.
- AAC’s statutory policyholder surplus was $757 million, down from $865 million. Everspan Indemnity’s statutory surplus increased to $106 million from $26 million, primarily due to $92 million of capital contributions from AFG.
- AFG, the holding company, had $269 million of net assets excluding investments in subsidiaries, of which $142 million was considered highly liquid. Management stated that current resources were sufficient for near-term needs, but dividends from AAC and Everspan are not expected for the foreseeable future.
- Derivative collateral and margin posted by AFS totaled $133 million at year-end 2021. The filing states that current collateral and margin obligations were being met.
Material Changes Versus the Prior Comparable Period
- Net loss attributable to common stockholders narrowed substantially to $17 million from $437 million, primarily due to favorable loss development, derivative gains, lower interest expense and the debt extinguishment gain.
- Loss and loss expenses shifted from a $225 million expense to an $88 million benefit, largely due to favorable development in Puerto Rico-related public finance exposures and RMBS.
- Operating expenses increased by $34 million due to Everspan hiring and launch costs, Xchange expenses and higher legal and consulting costs.
- Financial guarantee net par exposure declined 17% to $28.020 billion from $33.888 billion. Adversely classified exposure declined 25% to $6.361 billion, and watch-list exposure declined 19% to $3.824 billion.
- Ambac completed $2.695 billion of risk-reduction transactions, including $1.695 billion of quota-share reinsurance, as well as refinancings and commutations.
- AFG contributed $92 million of capital to Everspan and completed the acquisition of Providence Washington Insurance Company on October 1, 2021. The acquisition of the 21st Century Companies was completed on January 3, 2022.
- Net cash used in operating activities improved by $44 million, but remained negative. Investment portfolio carrying value declined by $589 million, primarily due to debt refinancing, asset sales and liquidity uses.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide formal quantitative earnings or revenue guidance. Management’s stated strategy is to grow and diversify Everspan, build a federation of specialty MGA/U partners, pursue strategic investments, reduce legacy financial guarantee risk, recover losses through litigation and evaluate transactions that could maximize shareholder value.
Puerto Rico remains a major contingency. Ambac reported $1.054 billion of net par exposure and $2.423 billion of net insured debt service to Puerto Rico and related entities at year-end 2021. The Commonwealth plan of adjustment and PRIFA and CCDA qualifying modifications had been confirmed or approved after year-end but remained subject to appeals and potential stays. A separate PRHTA plan of adjustment was expected later in 2022. The value and timing of contingent value instruments, new bonds and cash recoveries remain uncertain.
Ambac recorded $1.704 billion of net RMBS representation-and-warranty subrogation recoveries. Management stated that failure to recover these amounts would reduce stockholders’ equity from $1.098 billion to approximately negative $606 million. The filing also states that a stress scenario involving public finance losses could reduce equity to approximately $743 million, while loss of the recorded RMBS recoveries could reduce equity to approximately negative $607 million.
Key risks include inadequacy or volatility of loss reserves, adverse Puerto Rico developments, unsuccessful RMBS litigation recoveries, AAC rehabilitation or regulatory intervention, substantial debt and refinancing needs, restricted subsidiary dividends, interest-rate and foreign-exchange volatility, LIBOR transition, reinsurer credit risk, Everspan underwriting and rating risk, competition, cybersecurity, litigation and impairment of Xchange goodwill or intangible assets.
Unusual 2021 items included a $33 million gain from extinguishment of debt, the $1.175 billion Sitka refinancing, $92 million of Everspan capital contributions, favorable prior-year loss development, and significant portfolio de-risking transactions. KPMG issued unqualified opinions on the consolidated financial statements and internal control over financial reporting.
Important Facts for Investors to Verify
- Confirm the issuer identity: the provided filing is for Ambac Financial Group, Inc., while the request metadata names Octave Specialty Group Inc.
- Track the outcome and effective date of Puerto Rico restructuring plans, appeals, stays and the PRHTA plan of adjustment.
- Assess the collectability, timing and valuation assumptions supporting the $1.704 billion of net RMBS litigation recoveries.
- Review AAC’s ability to meet or refinance $2.334 billion of non-VIE principal debt, including the Sitka AAC Note and surplus notes.
- Monitor OCI approval requirements, accrued surplus-note interest and the likelihood of future dividends or other value transfers from AAC.
- Evaluate Everspan’s underwriting results, capital needs, reinsurance protection and continued “A-” AM Best rating as the platform scales.
- Review the sensitivity of reserves, investments and liquidity to interest rates, foreign exchange, COVID-19-related credit deterioration and LIBOR replacement.
- Reconcile GAAP stockholders’ equity of $1.098 billion with adjusted book value of $874 million and understand the impact of insurance intangibles, unearned premiums and unrealized investment losses.